Company Email Format Management

TRexBio

Biotechnology Research 681 Gateway Blvd 55 employees

Employees: 55
Contacts: 4
Emails: 4
Phones: 2

trex.bio LinkedIn Crunchbase

TRexBio Overview

Headquarters: 681 Gateway Blvd
Website: trex.bio
Industry: Biotechnology Research
Employees: 55
Founded: 2018
Funding: 84.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology T Cell Biology Regulatory T Cell Treg Immunology Inflammation Atopic Dermatitis

About TRexBio

TRexBio is a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue Treg biology by leveraging cutting-edge computational biology tools, a focus on human tissue, and deep immunobiology expertise. The company’s Deep Biology platform maps human tissue Treg behavior to disease processes to identify and characterize novel targets for therapeutic intervention. Our lead program TRB-061, currently in a Ph1 clinical trial for atopic dermatitis, is a novel TNFR2-selective agonist designed to activate and expand effector Tregs in the tissue and restore immune balance in inflammatory diseases. TRexBio is headquartered in South San Francisco, California. For more info, visit www.trex.bio.

TRexBio Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

TRexBio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Michelle E.	Global Human Resources Leader	Belmont, California, United States	Email
Carolyn Gabus	Clinical Operations Leader - Clinical	Palo Alto, California, United States	Email
Michael Baran	Partner - Pfizer Ventures	New York City Metropolitan Area, United States	Email Phone
Edith Rodriguez		San Francisco, California, United States	Email Phone